• Free Consultation
  • Products
    • LighthouseAI
    • NavigateSOM
      • About
      • Features & Capabilities
      • Implementation
  • Services
    • State Licensing
    • Assessments & Custom Research
    • Certification, Credentialing & Accreditation
      • NABP Drug Distributor Accreditation
      • Pharmacy Accreditations
    • Regulatory Affairs
      • Puerto Rico Regulatory Filings
      • DEA Consulting
      • State Inspection Preparation
      • Policy & Procedure Development
    • Fingerprinting
    • Training
      • Designated Representative Courses
  • Customers
    • 503A
    • 503B
    • Healthcare Providers
    • Manufacturer
    • Pharmacy
    • Repackager
    • Reverse Distributors
    • Third-Party Logistics Provider (3PL)
    • Virtual Manufacturer (VM)
    • Wholesale Distributor (WDD)
  • About Us
    • About the Company
    • About Our Team
    • Careers
    • Testimonials
  • Resources
    • Webinars
    • Whitepapers
  • Blog
  • Subscribe
  • Contact Us
Alabama’s New Rule Has Massive DSCSA Implications on State Regulations

Alabama’s New Rule Has Massive DSCSA Implications on State Regulations

by James DeFranco | May 24, 2023 | Uncategorized

Alabama’s New Rule Has Massive DSCSA Implications on State Regulations | by: Sumeet Singh, Founder & Chairman | Article Posted: May 24, 2023 | In 2013, the United States Congress passed the Drug Supply Chain Security Act (DSCSA) with the aim of safeguarding...
FDA – OA REMS Announcement Concerning requirements to Manufacturers of Opioids

FDA – OA REMS Announcement Concerning requirements to Manufacturers of Opioids

by James DeFranco | May 2, 2023 | Uncategorized

New FDA – OA REMS Announcement | by: Deneen Fumich, RPh | Article Posted: May 2, 2023 | April 21, 2022, FDA published in the Federal Register open comments under the Support Act which authorized FDA to require through a Risk Evaluation and Mitigation Strategy...
Oklahoma Pharmacy Board Unanimously Approves New Rules for Shipping Mail-Order Medications

Oklahoma Pharmacy Board Unanimously Approves New Rules for Shipping Mail-Order Medications

by James DeFranco | Apr 5, 2023 | Uncategorized

 | New Oklahoma Rules for Shipping Mail-Order Medications | by: Deneen Fumich, RPh | Article Posted: April 5, 2023 | Pharma Solutions reported on January 4, 2023, Oklahoma was requesting comments from business entities affected by the proposed rule change focusing on...
Final FDA Guidance for Federal Food, Drug, and Cosmetic Act

Final FDA Guidance for Federal Food, Drug, and Cosmetic Act

by James DeFranco | Apr 5, 2023 | Uncategorized

  Final FDA Guidance: Federal Food, Drug, and Cosmetic Act | by: Deneen Fumich, RPh | Article Posted: April 5, 2023 | On March 16, 2023, FDA announced: “the availability of a final guidance for industry entitled Definitions of Suspect Product and Illegitimate Product...
LighthouseAI: Compliance Automation Reduces Risk and Time

LighthouseAI: Compliance Automation Reduces Risk and Time

by James DeFranco | Mar 2, 2023 | Uncategorized

New: Compliance Automation Reduces Risk and Time  | by: Sumeet Singh, Founder & Chairman | Article Posted: March 2, 2023 | Pharma Solutions is the exclusive partner and distributor of LighthouseAI™, a comprehensive AI-based compliance solution to mitigate risk and...
<12345...>Last >

Pharma Solutions supports the drug and device supply chain by leveraging innovation and leading experts in the industry. Our commitment to providing purpose-built technology solutions, tailored consulting, and dedicated administrative support ensures our clients meet their business and compliance objectives

QUICK LINKS

  • Home
  • Free Consultation
  • Solutions
  • Customers
  • Company
  • Resources
  • Blog
  • Contact Us

CONTACT US

(484) 800-1863

hello@pharma.solutions

705 Montgomery Avenue, Suite 200 Penn Valley, PA 19072

Book Your FREE Consultation

© Copyright 2025 by Pharma Solutions USA, Inc. All Rights Reserved.